NCT04484051View on ClinicalTrials.gov

Growth Hormone Study in Adults With Prader-Willi Syndrome

Not yet recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2026

Conditions
Prader-Willi Syndrome
Trial Locations (1)

3015GD

Erasmus MC, University Medical Center Rotterdam, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Foundation for Prader-Willi Research

OTHER

collaborator

Prader-Willi Fonds

UNKNOWN

lead

Erasmus Medical Center

OTHER

NCT04484051 - Growth Hormone Study in Adults With Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter